Fake medicines – imminent risks to global health
Jamil Chade, Journalist
Mario Ottiglio, IFPMA
David Taylor, Professor of Pharmaceutical and Public Health Policy, UCL School of Pharmacy
Robert Johnstone, Board Member, IAPO
Luc Besancon, Acting General Secretary for Professional, Scientific and External affairs, International Pharmaceutical Federation
Martin Bernhardt, Vice President International Institutions, Sanofi
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.
Learn more
Related news and resources
Substandard and falsified medical products (EB152)
On 1 February 2023, IPSF submitted a statement delivered on behalf of IPSF, IAPO, and IFPMA for the WHO EB152 agenda item related to substandard and falsified medical products.
Read moreTechnology Transfer: A Collaborative Approach to Improve Global Health
The transfer of advanced technology is essential for economic development. It enables countries to accelerate the acquisition of knowledge, experience and equipment related to advanced, innovative industrial products and processes. This, in turn, builds the skills of the local workforce and creates new high-tech employment opportunities.
Read more
Optimising Post-Approval Change Management to Facilitate Continuous Supply of Medicines and Vaccines of High Quality Worldwide
Industry acknowledges its commitment to continue improving its strategic and predictive planning and proactive communication of changes to help facilitate global supply.
Read more